SLS and TERN are advancing leukemia therapies, with TERN-701 targeting CML and GPS positioned as a Phase 3 maintenance immunotherapy in AML. ・Sellas is approaching a Phase 3 Regal survival readout, a key catalyst investors are watching closely through 2026.

The next 10 months might be challenging for this biotech.

In this article, we will be taking a look at the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. According to research, the U.S. pharmaceutical industry was estimated at $634.32 billion in 2024 and is expected to reach $883.97 billion by ...

Acurx Pharmaceuticals Inc ACXP shares are trading sharply higher Wednesday afternoon despite a lack of company-specific news during the session. The move may reflect continued investor reaction to Monday's press release detailing progress for its lead antibiotic candidate,

Moderna's shares could soar as it advances its mRNA platform. Compared to older vaccines, those of the mRNA variety have advantages, including being much faster to produce and sometimes eliciting stronger,

Kunal Kamble, senior technical research analyst at Bonanza, has recommended buying shares of Aurobindo Pharma, Granules India, and Wheels India today

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, top-performing sectors, and what’s next for biotech investors.

Moderna's full pipeline may fuel long-term growth.

New stablecoin strategy fuels investor optimism.